Matches in Wikidata for { <http://www.wikidata.org/entity/Q67128956> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q67128956 description "clinical trial" @default.
- Q67128956 description "ensayu clínicu" @default.
- Q67128956 description "klinisch onderzoek" @default.
- Q67128956 description "клінічне випробування" @default.
- Q67128956 name "Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma" @default.
- Q67128956 name "Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma" @default.
- Q67128956 type Item @default.
- Q67128956 label "Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma" @default.
- Q67128956 label "Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma" @default.
- Q67128956 prefLabel "Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma" @default.
- Q67128956 prefLabel "Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma" @default.
- Q67128956 P1050 Q67128956-77D53D73-7D1A-43A6-8380-D87444F41077 @default.
- Q67128956 P1132 Q67128956-9AF5BD30-8C59-46CB-BEEB-80E47338DBFA @default.
- Q67128956 P1476 Q67128956-68A9F203-A070-415B-9A71-3ED1E62FC5B4 @default.
- Q67128956 P17 Q67128956-4C899CC0-53E2-4F1C-A9D4-8242BC90C4C2 @default.
- Q67128956 P2899 Q67128956-65CF15D0-6E08-4864-A971-7A72DB5ED071 @default.
- Q67128956 P3098 Q67128956-C21C44A0-217C-4296-92F8-82D80FE01AFC @default.
- Q67128956 P31 Q67128956-6679CC3F-4864-4D80-AB64-B45EE267EC0E @default.
- Q67128956 P4844 Q67128956-9C8E0E88-8C3C-4857-AF6B-18A4A4DBAFCF @default.
- Q67128956 P4844 Q67128956-A708C48C-0CB4-42B9-A3F8-14BF86A981D0 @default.
- Q67128956 P580 Q67128956-6712A1E5-B287-4D3E-A340-90D797533392 @default.
- Q67128956 P582 Q67128956-23D4AE92-5DE0-4D34-8077-8D5DA6698C5F @default.
- Q67128956 P6099 Q67128956-30AB7F51-F17D-4E18-AC5F-2E967059EAD1 @default.
- Q67128956 P8363 Q67128956-F050F208-C903-4935-9A81-1A2A873EA2FB @default.
- Q67128956 P1050 Q33525 @default.
- Q67128956 P1132 "+57" @default.
- Q67128956 P1476 "A Phase I/Ib, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab (MK-3475) in Combination With Vorinostat in Patients With Advanced Renal or Urothelial Cell Carcinoma" @default.
- Q67128956 P17 Q30 @default.
- Q67128956 P2899 "+18" @default.
- Q67128956 P3098 "NCT02619253" @default.
- Q67128956 P31 Q30612 @default.
- Q67128956 P4844 Q13896859 @default.
- Q67128956 P4844 Q905901 @default.
- Q67128956 P580 "2016-01-14T00:00:00Z" @default.
- Q67128956 P582 "2019-05-31T00:00:00Z" @default.
- Q67128956 P6099 Q5452194 @default.
- Q67128956 P8363 Q78089383 @default.